PROTAGONIST THERAPEUTICS INC (PTGX) Stock Earnings Estimates

USA Nasdaq NASDAQ:PTGX • US74366E1029

84.49 USD
+3.82 (+4.74%)
At close: Feb 6, 2026
84.49 USD
0 (0%)
After Hours: 2/6/2026, 8:01:34 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PTGX revenue by date.PTGX revenue by date.
26.58M
-2.85%
60M
125.73%
434.433M
624.06%
51.856M
-88.06%
264.16M
409.41%
145.73M
-44.83%
278.62M
91.19%
486.72M
74.69%
689.48M
41.66%
911.88M
32.26%
1.139B
24.91%
1.336B
17.30%
EBITDA
YoY % growth
PTGX ebitda by date.PTGX ebitda by date.
-130.34M
-4.24%
-90.34M
30.69%
255.738M
383.08%
-148.008M
-157.87%
71.415M
148.25%
-58.288M
-181.62%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PTGX ebit by date.PTGX ebit by date.
-131.37M
-4.39%
-93.652M
28.71%
252.843M
369.98%
-151.762M
-160.02%
25.114M
116.55%
-97.911M
-489.87%
35.515M
136.27%
163.68M
360.88%
375.81M
129.60%
683.81M
81.96%
900.23M
31.65%
1.071B
18.97%
Operating Margin
PTGX operating margin by date.PTGX operating margin by date.
-494.24%-156.09%58.20%-292.66%9.51%-67.19%12.75%33.63%54.51%74.99%79.04%80.16%
EPS
YoY % growth
PTGX eps by date.PTGX eps by date.
-2.60
3.70%
-1.49
42.69%
4.20
381.88%
-1.96
-146.64%
-0.14
92.62%
-1.29
-790.82%
1.25
196.86%
2.38
90.88%
4.32
81.58%
5.79
33.96%
7.79
34.51%
9.26
18.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.55
-128.01%
-0.53
-179.91%
0.05
109.93%
-0.12
80.20%
-0.39
30.33%
Revenue
Q2Q % growth
9.105M
-94.66%
18.399M
-35.03%
32.279M
482.02%
90.245M
1,815.22%
122.11M
1,241.13%
EBITDA
Q2Q % growth
-50.916M
-139.26%
-909.84K
95.23%
-2.19M
94.72%
-2.515M
94.47%
N/A
EBIT
Q2Q % growth
-44.537M
-135.13%
-45.926M
-137.83%
81.626M
294.16%
20.324M
143.78%
53.108M
219.25%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.62
-14.81%
-0.650.034.88%
Q2 2025
Q2Q % growth
-0.55
-10.00%
-0.590.046.78%
Q1 2025
Q2Q % growth
-0.19
-105.83%
-0.240.0519.40%
Q4 2024
Q2Q % growth
1.98
350.00%
0.331.65504.52%
Q3 2024
Q2Q % growth
-0.54
6.90%
-0.620.0812.85%
Q2 2024
Q2Q % growth
-0.50
26.47%
-0.610.1118.53%
Q1 2024
Q2Q % growth
3.26
586.57%
1.222.04167.72%
Q4 2023
Q2Q % growth
0.44
163.77%
-0.030.471,399.31%
Q3 2023
Q2Q % growth
-0.58
9.38%
-0.710.1318.05%
Q2 2023
Q2Q % growth
-0.68
19.05%
-0.66-0.02-2.99%
Q1 2023
Q2Q % growth
-0.67
-55.81%
-0.740.079.61%
Q4 2022
Q2Q % growth
-0.69
10.39%
-0.65-0.04-5.98%
Q3 2022
Q2Q % growth
-0.64
8.57%
-0.890.2527.71%
Q2 2022
Q2Q % growth
-0.84
-21.74%
-0.950.1111.13%
Q1 2022
Q2Q % growth
-0.43
20.37%
-0.640.2132.91%
Q4 2021
Q2Q % growth
-0.77
-60.42%
-0.800.033.53%
Q3 2021
Q2Q % growth
-0.70
-233.33%
-0.68-0.02-2.43%
Q2 2021
Q2Q % growth
-0.69
-13.11%
-0.56-0.13-23.64%
Q1 2021
Q2Q % growth
-0.54
25.00%
-0.580.046.79%
Q4 2020
Q2Q % growth
-0.48 -0.490.011.55%
Q3 2020
Q2Q % growth
-0.21 -0.620.4166.39%
Q2 2020
Q2Q % growth
-0.61 -0.610.00-0.51%
Q1 2020
Q2Q % growth
-0.72 -0.71-0.01-2.01%
PTGX Yearly EPS VS EstimatesPTGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
4.712M
0.79%
3.709M1.003M27.04%
Q2 2025
Q2Q % growth
5.546M
33.09%
6.942M-1.396M-20.11%
Q1 2025
Q2Q % growth
28.321M
-88.89%
31.053M-2.732M-8.80%
Q4 2024
Q2Q % growth
170.638M
184.40%
51.36M119.278M232.24%
Q3 2024
Q2Q % growth
4.675M 2.113M2.562M121.25%
Q2 2024
Q2Q % growth
4.167M 8.16M-3.993M-48.93%
Q1 2024
Q2Q % growth
254.953M 122.4M132.553M108.29%
Q4 2023
Q2Q % growth
60M 40.8M19.2M47.06%
Q3 2023
Q2Q % growth
8.5M-8.5M-100.00%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
2.04M-2.04M-100.00%
Q4 2022
Q2Q % growth

-100.00%
5.1M-5.1M-100.00%
Q3 2022
Q2Q % growth

-100.00%
%
Q2 2022
Q2Q % growth
860K
-62.11%
390.997K469.003K119.95%
Q1 2022
Q2Q % growth
25.72M
315.51%
17.391M8.329M47.89%
Q4 2021
Q2Q % growth
8.62M
52.57%
5.173M3.447M66.63%
Q3 2021
Q2Q % growth
10.29M
-21.51%
1.778M8.512M478.74%
Q2 2021
Q2Q % growth
2.27M
-63.50%
5.275M-3.005M-56.97%
Q1 2021
Q2Q % growth
6.19M
69.59%
1.53M4.66M304.58%
Q4 2020
Q2Q % growth
5.65M 3.188M2.462M77.23%
Q3 2020
Q2Q % growth
13.11M 2.193M10.917M497.81%
Q2 2020
Q2Q % growth
6.22M 2.584M3.636M140.71%
Q1 2020
Q2Q % growth
3.65M 1.51M2.14M141.72%
PTGX Yearly Revenue VS EstimatesPTGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS9.89% 17.61% -0.24% 3.55%
Revenue0% -66.47% -23.46% -18.87%